Is CVE-2026-31070 in the CISA KEV catalog?

No. CVE-2026-31070 is not currently on the CISA Known Exploited Vulnerabilities list.

What is the CVSS severity of CVE-2026-31070?

CVE-2026-31070 has a CVSS v3 base score of 9.8 (CRITICAL).

What is the EPSS score for CVE-2026-31070?

CVE-2026-31070 has an EPSS score of 0.48% (37th percentile), estimating the probability of exploitation in the next 30 days.

CVE & CISA-KEV Catalog

CVE-2026-31070

CRITICAL

9.8

CVSS v3

NVD

Description

The LalanaChami Pharmacy Management System (commit 5c3d028) allows unauthenticated remote attackers to escalate privileges by self-assigning an administrative role during registration. The /api/user/signup endpoint fails to validate the role parameter in the request body

CWE-269Improper Privilege Management

CVSS v3 Vector

Exploitability

Attack VectorNetwork

Attack ComplexityLow

Privileges RequiredNone

User InteractionNone

ScopeUnchanged

Impact

ConfidentialityHigh

IntegrityHigh

AvailabilityHigh

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Exploit Intelligence

0.48%probability of exploitation in 30 days

37thpercentile

Low risk: more likely to be exploited than 37% of all known CVEs.

References

Find and fix vulnerabilities across your fleet

TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.

Start free

This product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2026-05-20.